New GLP-1 pill helps people lose 23 pounds in study
Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial.
Aug 27, 2025
0
40
MeSH tree: D09.400.430.825
Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial.
Aug 27, 2025
0
40
Researchers from the Global Center for Asian Women's Health (GloW) and the Department of Obstetrics and Gynecology at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have found that selected ...
Aug 19, 2025
0
31
A Phase III, international, randomized clinical trial assessed the safety and efficacy of canagliflozin for the treatment of type 2 diabetes mellitus (T2DM) in children and adolescents.
Aug 4, 2025
0
17
People in the UK eat a median of eight different plants a day—including spices and fat-based oils—with some eating just two daily.
Jul 29, 2025
0
19
The Enhanced Primary Care Diabetes (EPCD) model is a nurse-led care delivery model that leverages multidisciplinary support to improve diabetes care quality in primary care settings. A study titled "Diabetes care delivery ...
Jul 29, 2025
0
14
Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small study being presented Saturday ...
Jul 12, 2025
0
40
Once-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated hemoglobin (HbA1c) among adults with type 2 diabetes, according to a study published online June ...
Jun 27, 2025
0
17
Food is medicine (FIM) programs that incorporate healthy food into health care for people with or at high risk for chronic disease show great potential in improving diet quality and food security, but additional research ...
Jun 18, 2025
0
16
A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) should be considered as an option for individuals with type 1 diabetes who want an alternative to using ...
Mar 21, 2025
0
25
Not all fat is created equal when it comes to weight loss and health. While subcutaneous fat—the fat stored just under the skin—can be neutral or even beneficial, visceral fat is a different story. This deep belly fat, which ...
Mar 5, 2025
0
39